A dose‐finding study for hemoporfin in photodynamic therapy for port‐wine stain: A multicenter randomized double‐blind phase IIb trial
- 22 April 2018
- journal article
- research article
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 34 (5) , 314-321
Abstract
Summary: Background/Purpose: Previous studies have shown that hemoporfin‐mediated photodynamic therapy (PDT) was a treatment for port‐wine stain (PWS). Our current study aimed to identify optimal hemoporfin dose.Methods: A prospective, multicenter, double‐blind, randomized clinical trial was conducted. Patients were assigned into low‐ or high‐dose hemoporfin (2.5 mg/kg and 5 mg/kg intravenously, respectively), or control (placebo) group, at a rate of 2:2:1. Treatment efficacy was evaluated at week 8. Then, patients in control group were randomly assigned into either high‐ or low‐dose hemoporfin group. Treatment reactions and adverse events were analyzed at week 16.Results: A total of 100 patients (40, 40, 20 in low‐, high‐dose hemoporfin, and control group, respectively) were enrolled. Compared to low dose (40%) and control group (15%), a higher proportion of patients in high‐dose group (75%) had achieved skin lesion improvements. Treatment satisfactions were graded highest in high‐dose group. Compared to low‐dose group (14.3%), high‐dose group (46.0%) had more frequent skin hyperpigmentation, which disappeared 3‐6 months after treatment. Other treatment reactions and adverse events were comparable between two groups.Conclusions: Photodynamic therapy with 5 mg/kg hemoporfin could be an effective and safe treatment for PWS.Keywords
Funding Information
- Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co Ltd (102007)
This publication has 24 references indexed in Scilit:
- Tolerance and pharmacokinetics of single-dose intravenous hemoporfin in healthy volunteersActa Pharmacologica Sinica, 2011
- Efficacy and safety of hemoporfin in photodynamic therapy for port‐wine stain: a multicenter and open‐labeled phase IIa studyPhotodermatology, Photoimmunology & Photomedicine, 2011
- Photodynamic therapy of port-wine stainsJournal of Dermatological Treatment, 2010
- Long‐pulsed neodymium:yttrium‐aluminum‐garnet laser treatment for hypertrophic port‐wine stains on the lipsJournal of Cosmetic and Laser Therapy, 2009
- Treatment of pulsed dye laser–resistant port wine stain birthmarksJournal of the American Academy of Dermatology, 2007
- Current treatment options for port wine stain birthmarksPhotodiagnosis and Photodynamic Therapy, 2007
- Involvement of Mitochondria–Caspase Pathway in Hemoporfin‐mediated Cell DeathPhotochemistry and Photobiology, 2007
- Laser therapy of vascular lesionsPhotodermatology, Photoimmunology & Photomedicine, 2006
- Phototoxicity of Hemoporfin to ovarian cancerBiochemical and Biophysical Research Communications, 2005
- Does fluence matter in the laser treatment of port-wine stains?Clinical and Experimental Dermatology, 2003